Skip to content
← Full study record

NCT01527045 · MORE INFO

Limitations, agreements, and source contact

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies · Source last updated 2020-01-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mmielcar@fredhutch.org
organization
Fred Hutchinson Cancer Research Center
phone
(206) 667-2827
title
Dr. Marco Mielcarek
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mmielcar@fredhutch.org
organization
Fred Hutchinson Cancer Research Center
phone
(206) 667-2827
title
Dr. Marco Mielcarek

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice